Globus Medical (GMED) said Thursday it has completed its all-cash $250 million acquisition of medical device company Nevro (NVRO).

The acquisition expands Globus Medical's footprint in the musculoskeletal market and unlocks a $2.5 billion market opportunity, the company said.

Nevro common stock ceased trading on the New York Stock Exchange before the market open on Thursday, Globus said.

Price: 72.15, Change: -3.35, Percent Change: -4.44